Advanced Search
Contact | Corporate | Help

Phase I/II Trial of Bevacizumab, Pemetrexed and Erlotinib in Elderly Patients With Non-Small Cell Lung Cancer.

Sponsors:
  • H. Lee Moffitt Cancer Center and Research Institute
  • Genentech
  • Eli Lilly and Company
Phases:
  • Phase I
  • Phase II
IndicationsAcronym:
  • Non-Small Cell Lung Cancer
Age Groups:
  • Senior
Gender:
Both
Names:
  • Drug: Bevacizumab
  • Drug: Erlotinib
  • Drug: Pemetrexed
Enrollment:
9

Additional information about NCT00351039.


SourceSolution © 2008-2012